Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
Muscle mass loss and wasting are characteristic features of patients with chronic conditions including cancer. Therapeutic options are still scarce. We hypothesized that cachexia-induced muscle oxidative stress may be attenuated in response to treatment with beta2-adrenoceptor-selective agonist form...
Main Authors: | Anna Salazar-Degracia, Sílvia Busquets, Josep M. Argilés, Francisco J. López-Soriano, Esther Barreiro |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2017-12-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/4109.pdf |
Similar Items
-
Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis
by: Ashraf Velayati, et al.
Published: (2015-01-01) -
Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01) -
Medium‐Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway
by: Jianlin Zhang, et al.
Published: (2024-04-01) -
Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
by: Rachel L. Nosacka, et al.
Published: (2020-06-01) -
Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)